Advanced or Recurrent Endometrial Cancer Clinical Trial

0 Views
administrator
administrator
07/09/23

The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next